Header image

Concurrent Session 5A: Abstract Session - National innovations in viral hepatitis

Tracks
.
Saturday, August 3, 2024
11:45 AM - 12:45 PM
Auditorium 2

Speaker

VH2024 Conference

Welcome & Introduction

11:45 AM - 11:50 AM

Biography

Agenda Item Image
Ms Nicole Matthews
Research Coordinator
Burnet Institute

Effective use of Notifications Data to Advance Hepatitis C Elimination by 2030

11:50 AM - 12:05 PM

Biography

As the Research Coordinator for Connect C at Burnet Institute, Nicole is working with Australian health authorities and community to co design interventions aimed at overcoming barriers in the utilisation of notifications systems. Prior to Burnet, Nicole delivered health programs in hepatitis C, Spinal Surgery, Pain management and medical examinations.
A/Prof Behzad Hajarizadeh
Associate Professor
The Kirby Institute, UNSW

Anti-viral treatment levels among treatment-eligible people living with chronic hepatitis B in Australia: The REACH-B Study

12:05 PM - 12:20 PM

Biography

A/Prof Hajarizadeh trained as a Medical Practitioner and has a Masters in Public Health and PhD in Medicine (Clinical Epidemiology). His main area of expertise is viral hepatitis with more than 15 years experience as a clinician and then researcher in the field of liver diseases.
Agenda Item Image
Dr Nick Scott
Head, Modelling & Biostatistics
Burnet Institute

Return on investment for a prison-based needle and syringe program in Australia

12:20 PM - 12:35 PM

Biography

Associate Professor Nick Scott is the head of Modelling and Biostatistics at the Burnet Institute. He uses economic modelling to inform public health policy.
Ms Andrea Pizzie
Lead Policy Analyst
Hepatitis Australia

Cost-effectiveness of investment projects to support Australia’s national hepatitis strategies

12:35 PM - 12:40 PM

Biography

Andrea Pizzie is the Lead Policy Analyst for Hepatitis Australia.
Agenda Item Image
Dr. Guillaume Fontaine
Assistant Professor
UNSW / Kirby Institute

Evaluating the impact theory of the National Australian Hepatitis C Point-of-Care Testing Program: An implementation science-informed study

12:40 PM - 12:45 PM

Biography

Dr. Guillaume Fontaine is an Assistant Professor at McGill University, and a Visiting Fellow at the Kirby Institute, UNSW Sydney. As an implementation scientist, he navigates the complex terrain of bringing scientific advancements into everyday use, devising strategies to overcome barriers and ensure that research findings effectively enhance healthcare outcomes.

Chairperson

Agenda Item Image
Greg Dore
Head, Viral Hepatitis Clinical Research Program, Infectious Disease Physician St Vincent’s Hospital Sydney
The Kirby Institute

Agenda Item Image
Alisa Pedrana
Senior Research Fellow
Burnet Institute

loading